retatrutide weight loss clinical trial for Loss: TRIUMPH-1 Results, Cost, Insurance Retatrutide FDA Approval Status 2026:

If anything, this experience reinforced how important it is for those of us taking GLP-1 medications to focus on nutrient-dense foods and not just appetite suppression

For you as someone considering or using these medications, the practical takeaway is straightforward

Ongoing physician oversight for optimal results and fewer side effects

These effects are directly related to the medication's mechanism of slowing gastric emptying and affecting gut motility

In light of increasing GLP-1RA use and these significant knowledge gaps, we conducted a structured literature search in March 2024 using the terms GLP-1 receptor agonists AND inflammatory bowel disease OR ulcerative colitis OR Crohns disease. This narrative review is, to our knowledge, the first to comprehensively explore the pathophysiological rationale, pre-clinical evidence, and clinical considerations of GLP-1RA use in IBD

Patients who adopt consistent meal timing, prioritize protein intake, and maintain hydration typically see weight loss emerge 1 to 2 weeks earlier than those without lifestyle modifications